Bringing physiology into PET of the liver

Journal of Nuclear Medicine

Volumn 53, Issue 3, 2012, Pages 425-433

  Keiding, Susanne ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Liver function; Liver hemodynamics; Liver metabolism; Liver PET; PET kinetics

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PALMITIC ACID C 11;

BILE FLOW; COMPARTMENT MODEL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG CLEARANCE; DRUG METABOLISM; FATTY ACID METABOLISM; GLUCOSE METABOLISM; HEPATIC ARTERY; HUMAN; IMAGE ANALYSIS; ISOTOPE LABELING; ISOTOPE TRACING; LIVER BLOOD FLOW; LIVER FUNCTION; LIVER METABOLISM; LIVER PERFUSION; METABOLITE; MICROCIRCULATION; PORTAL VEIN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; REVIEW; STEADY STATE;

ALGORITHMS; ANIMALS; BILE ACIDS AND SALTS; FATTY ACIDS; GALACTOSE; GLUCOSE; HEPATIC ARTERY; HUMANS; LIVER; LIVER CIRCULATION; METABOLIC CLEARANCE RATE; MICROCIRCULATION; MODELS, BIOLOGICAL; PORTAL VEIN; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84858597263     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.100214     Document Type: Review

References (49)

1. Merkel C, Montagnese S, Amodio P. Functional anatomy of liver circulation. In: Keiding S, Sørensen S, eds. Functional Molecular Imaging in Hepatology. Sharjah, UAE: Bentham Science Publishers; 2012:3-13.
2. Sørensen M. Hepatocellular carcinoma. In: Keiding S, Sørensen S, eds. Functional and Molecular Imaging in Hepatology. Sharjah, UAE: Bentham Science Publishers; 2012:87-94.
3. Prytz H. Cholangiocarcinoma. In: Keiding S, Sørensen S, eds. Functional and Molecular Imaging in Hepatology. Sharjah, UAE: Bentham Science Publishers; 2012:95-103.
4. Jones-Jackson LB, Walker RC, Delbeke D. Liver metastases from colorectal cancers. In: Keiding S, Sørensen S, eds. Functional and Molecular Imaging in Hepatology. Sharjah, UAE: Bentham Science Publishers; 2012:104-119.
5. Ambrosini V, Campana D, Tommassetti P, Fanti S. Neuroendocrine tumours with secondary liver lesions. In: Keiding S, Sørensen S, eds. Functional and Molecular Imaging in Hepatology. Sharjah, UAE: Bentham Science Publishers; 2012:120-128.
6. Winterdahl M, Keiding S, Sørensen M, Mortensen FV, Alstrup AKO, Munk OL. Tracer input for kinetic modelling of liver physiology determined without sampling portal venous blood in pigs. Eur J Nucl Med Mol Imaging. 2011;38:263-270.
7. Munk OL, Bass L, Roelsgaard K, et al. Liver kinetics of glucose analogs measured in pigs by PET: importance of dual-input blood sampling. J Nucl Med. 2001;42:795-801. (Pubitemid 32453472)
8. 18F]FDG uptake in the normal liver using dynamic PET: impact and modeling of the dual hepatic blood supply. J Nucl Med. 2001;42:1265-1273.
9. Iozzo P, Jarvisalo MJ, Kiss J, et al. Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs. Gastroenterology. 2007;132:531-542. (Pubitemid 46274671)
10. 15O PET images using tissue-derived arterial and portal input functions. Eur J Nucl Med Mol Imaging. 2008;35:1899-1911.
11. 18F]FDG PET images using tissue-derived input functions. Eur J Nucl Med Mol Imaging. 2009;36:2014-2026.
12. Rani S, Kooresh S. Reconstruction of liver dual input function by optimization of the hepatic artery (HA)-to-portal vein (PV) transfer function [abstract]. J Nucl Med. 2011;52(suppl):180P.
13. Choi Y, Hawkins RA, Huang SC, et al. Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver. J Nucl Med. 1994;35:818-823. (Pubitemid 24151217)
14. Munk OL, Keiding S, Bass L. Impulse-response function of splanchnic circulation with model-independent constraints: theory and experimental validation. Am J Physiol Gastrointest Liver Physiol. 2003;285:G671-G680. (Pubitemid 37151228)
15. Doi R, Inoue K, Kogire M, et al. Simultaneous measurements of hepatic arterial and portal venous flows by transit time ultrasound volume flowmetry. Surg Gynecol Obstet. 1988;167:65-69.
16. Winterdahl M, Munk OL, Sørensen M, Mortensen FV, Keiding S. Hepatic blood perfusion measured by 3-min dynamic FDG PET in pigs. J Nucl Med. 2011;52:1119-1124.
17. 11C-methyl-glucose in pig liver. J Nucl Med. 2001;42:1673-1678.
18. 11C]palmitate kinetics across the splanchnic bed in arterial, portal and hepatic venous plasma during fasting and euglycemic hyperinsulinemia. Nucl Med Biol. 2006;33:521-528.
19. Iozzo P, Bucci M, Roivainen A, et al. Liver fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals. Gastroenterology. 2010;139:846-856.
20. Keiding S, Munk OL, Roelsgaard K, Bender D, Bass L. Positron emission tomography of hepatic first-pass metabolism of ammonia in pig. Eur J Nucl Med. 2001;28:1770-1775.
21. 18F]fluoro-2- deoxy-galactose positron emission tomography. Am J Physiol Gastrointest Liver Physiol. 2008;295:G27-G36.
22. Gjedde A. Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination. Brain Res. 1982;257:237-274. (Pubitemid 12064128)
23. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1-7. (Pubitemid 13129630)
24. Sørensen M, Munk OL, Keiding S. Backflux of ammonia from brain to blood in human subjects with and without hepatic encephalopathy. Metab Brain Dis. 2009;24:237-242.
25. Prytz H, Keiding S, Björnsson E, et al. Dynamic FDG PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation. Hepatology. 2006;44:1572-1580. (Pubitemid 44953662)
26. Bass L, Keiding S, Winkler K, Tygstrup N. Enzymatic elimination of substrates flowing through the intact liver. J Theor Biol. 1976;61:393-409.
27. Keiding S, Johansen S, Winkler K, Tønnesen K, Tygstrup N. Michaelis-Menten kinetics of galactose elimination by the isolated perfused pig liver. Am J Physiol. 1976;230:1302-1313.
28. Crone C. The permeability of capillaries in various organs as determined by the use of the 'indicator diffusion' method. Acta Physiol Scand. 1963;58:292-305.
29. Munk OL, Keiding S, Bass L. Combining compartmental and microvascular models in interpreting dynamic PET data. In: Keiding S, Sørensen S, eds. Functional and Molecular Imaging in Hepatology. Sharjah, UAE: Bentham Science Publishers; 2012:24-31.
30. Munk OL, Keiding S, Bass L. Capillaries within compartments: microvascular interpretation of dynamic positron emission tomography data. J Theor Biol. 2003;225:127-141. (Pubitemid 37237618)
31. Munk OL, Bass L, Feng H, et al. Determination of regional flow by use of intravascular PET tracers: microvascular theory and experimental validation for pig livers. J Nucl Med. 2003;44:1862-1870. (Pubitemid 39663321)
32. Bass L, Sørensen M, Munk OL, Keiding S. Analogue tracers and lumped constant in capillary beds. J Theor Biol. 2011;285:177-181.
33. 18F] fluoro-2-deoxy-D-galactose PET/CT. J Nucl Med. 2011;52:1566-1572.
34. 18F-FDG PET study. J Nucl Med. 2003;44:682-689.
35. Iozzo P, Osman S, Glaser M, et al. In vivo imaging of insulin receptors by PET: preclinical evaluation of iodine-125 and iodine-124 labelled human insulin. Nucl Med Biol. 2002;29:73-82. (Pubitemid 34088164)
36. Borra R, Lautamäki R, Parkkola R, et al. Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus. Metabolism. 2008;57:1445-1451.
37. 18F]fluoro-6-thia- heptadecanoic acid and PET. Eur J Nucl Med Mol Imaging. 2003;30:1160-1164.
38. Iozzo P, Turpeinen AK, Takala T, et al. Defective liver disposal of free fatty acids in patients with impaired glucose tolerance. J Clin Endocrinol Metab. 2004;89:3496-3502. (Pubitemid 38951926)
39. Holden HM, Rayment I, Thoden JB. Structure and function of enzymes of the Leloir pathway for galactose metabolism. J Biol Chem. 2003;278:43885-43888. (Pubitemid 37377125)
40. Keiding S, Johansen S, Winkler K. Hepatic galactose elimination kinetics in the intact pig liver. Scand J Clin Lab Invest. 1982;42:253-259. (Pubitemid 12085124)
41. Tygstrup N. The galactose elimination capacity in control subjects and in patients with cirrhosis of the liver. Acta Med Scand. 1964;175:281-289.
42. Jepsen P, Vilstrup H, Ott P, Keiding S, Andersen PK, Tygstrup N. The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study. BMC Gastroenterology. 2009;9:50-56.
43. 18F]fluoro-2-deoxy-D-galactose from Talose triflate and biodistribution in a porcine model. Nucl Med Biol. 2011;38:477-483.
44. Grün BR, Berger U, Oberdorfer F, et al. Metabolism and actions of 2-deoxy-2-fluoro-D-galactose in vivo. Eur J Biochem. 1990;190:11-19. (Pubitemid 20183958)
45. Winkler K, Bass L, Keiding S, Tygstrup N. The physiologic basis of clearance measurements in hepatology. Scand J Gastroenterol. 1979;14:439-448. (Pubitemid 9232237)
46. Keiding S, Sørensen M. Hepatic removal kinetics: importance for quantitative measurements of liver function. In: Rodes J, Benhamou J-P, Dufour JF, Blei A, Reichen J, Rizzetto M, eds. Textbook of Hepatology: From Basic Science to Clinical Practice. 3rd ed. Oxford, UK: Blackwell; 2007:468-478.
47. Keiding S. Galactose clearance and liver blood flow. Gastroenterology. 1988;94:477-481. (Pubitemid 18054788)
48. 18F-fluoro-deoxy-galactose and PET/CT scanning [abstract]. Radiother Oncol. 2011;99(suppl 1):S67.
49. 11C]cholylsarcosine, a novel bile acid tracer for PET/CT of hepatic excretory function: radiosynthesis and proof-of-concept studies in pigs. J Nucl Med. 2012. In press.